OBJECTIVE: Schizophrenia is associated with a significantly high prevalence of smoking. Upregulation of neurotrophins by nicotine is well established. Accumulating evidence shows that brain-derived neurotrophic factor (BDNF) may be involved in the pathophysiology of schizophrenia. The purposes of this study were to compare BDNF levels in smokers to nonsmokers with schizophrenia and examine the association between BDNF levels and psychopathological symptoms. MATERIALS AND METHODS: Serum BDNF levels were measured in 139 male inpatients with DSM-IV schizophrenia: 102 smokers and 37 nonsmokers. Symptoms were assessed with the Positive and Negative Syndrome Scale (PANSS). RESULTS: The positive PANSS symptoms were lower in smokers than in nonsmokers, while the negative symptoms were lower in those who smoked more cigarettes. BDNF levels were significantly higher in smokers than in nonsmokers (p < 0.05). Higher BDNF levels correlated with fewer negative symptoms and with smoking more cigarettes. CONCLUSION: The fewer positive symptoms in smokers and fewer negative symptoms in those who smoked more cigarettes may be associated with nicotine-induced upregulation of BDNF.
OBJECTIVE:Schizophrenia is associated with a significantly high prevalence of smoking. Upregulation of neurotrophins by nicotine is well established. Accumulating evidence shows that brain-derived neurotrophic factor (BDNF) may be involved in the pathophysiology of schizophrenia. The purposes of this study were to compare BDNF levels in smokers to nonsmokers with schizophrenia and examine the association between BDNF levels and psychopathological symptoms. MATERIALS AND METHODS: Serum BDNF levels were measured in 139 male inpatients with DSM-IV schizophrenia: 102 smokers and 37 nonsmokers. Symptoms were assessed with the Positive and Negative Syndrome Scale (PANSS). RESULTS: The positive PANSS symptoms were lower in smokers than in nonsmokers, while the negative symptoms were lower in those who smoked more cigarettes. BDNF levels were significantly higher in smokers than in nonsmokers (p < 0.05). Higher BDNF levels correlated with fewer negative symptoms and with smoking more cigarettes. CONCLUSION: The fewer positive symptoms in smokers and fewer negative symptoms in those who smoked more cigarettes may be associated with nicotine-induced upregulation of BDNF.
Authors: Xiang Yang Zhang; Rui Ling Zhang; Miao Pan; Da Chun Chen; Mei Hong Xiu; Thomas R Kosten Journal: J Psychiatr Res Date: 2010-03-23 Impact factor: 4.791
Authors: Aitor Palomino; Ainara Vallejo-Illarramendi; Ana González-Pinto; Ana Aldama; Cristina González-Gómez; Fernando Mosquera; Gixane González-García; Carlos Matute Journal: Schizophr Res Date: 2006-07-10 Impact factor: 4.939
Authors: Undine E Lang; Thomas Sander; Falk W Lohoff; Rainer Hellweg; Malek Bajbouj; Georg Winterer; Jürgen Gallinat Journal: Psychopharmacology (Berl) Date: 2006-12-21 Impact factor: 4.530
Authors: Kristi A Sacco; Angelo Termine; Aisha Seyal; Melissa M Dudas; Jennifer C Vessicchio; Suchitra Krishnan-Sarin; Peter I Jatlow; Bruce E Wexler; Tony P George Journal: Arch Gen Psychiatry Date: 2005-06
Authors: Helton José Reis; Rodrigo Nicolato; Izabela Guimarães Barbosa; Paulo Henrique Teixeira do Prado; Marco Aurélio Romano-Silva; Antonio Lucio Teixeira Journal: Neurosci Lett Date: 2008-05-13 Impact factor: 3.046
Authors: Mumtaz Jamal; Willem Van der Does; Bernet M Elzinga; Marc L Molendijk; Brenda W J H Penninx Journal: Nicotine Tob Res Date: 2014-09-02 Impact factor: 4.244